Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Immunotherapy for Short Ragweed Allergy
NCT00670384Phase 2Withdrawn
- Sponsor
- Antigen Laboratories, Inc.
- Modality
- Biologic (Biologic)
01
Overview
A Phase 2 trial of short ragweed allergenic extract in allergic rhinitis (AR), sponsored by Antigen Laboratories, Inc.. Status: withdrawn.
02
Drugs
short ragweed allergenic extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00670384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00670384.